Decentralized Clinical Trials at Home: Commentary on Caregivers’ Burden
Decentralized clinical trials (DCTs) provide the opportunity to bring interventional studies closer to participants in their homes or a suitable location closer to prospective participants, thus increasing participants’ diversity, accrual, retention, health care, and research access. However, little...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748241305581 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846140022673113088 |
|---|---|
| author | Opeyemi Bolajoko PhD Dottington Fullwood EdD, CHES Mahin Colissa MPH Arnold Merriweather Callie Merriweather Folakemi T. Odedina PhD, BPharm |
| author_facet | Opeyemi Bolajoko PhD Dottington Fullwood EdD, CHES Mahin Colissa MPH Arnold Merriweather Callie Merriweather Folakemi T. Odedina PhD, BPharm |
| author_sort | Opeyemi Bolajoko PhD |
| collection | DOAJ |
| description | Decentralized clinical trials (DCTs) provide the opportunity to bring interventional studies closer to participants in their homes or a suitable location closer to prospective participants, thus increasing participants’ diversity, accrual, retention, health care, and research access. However, little is known about the burden of caring for cancer patients participating in DCTs. This article describes how DCTs might affect the caregivers of cancer patients. The points discussed include how technological challenges for those without adequate digital literacy can overburden participants and their caregivers at home, as well as managing and optimizing research logistics and safe handling of samples. In addition, the shift in labor from the study personnel to the participants and their caregivers in a bid to complete several study procedures on their own can increase the care burden, especially if not well incentivized. Therefore, it is important to accumulate evidence on ways to optimize DCTs, especially in the home environment, without increasing the burden on caregivers, who will be an integral part of the study team and support the research at home. |
| format | Article |
| id | doaj-art-dc5c9d9d302b42e1a2f00afe186a6ba3 |
| institution | Kabale University |
| issn | 1526-2359 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Cancer Control |
| spelling | doaj-art-dc5c9d9d302b42e1a2f00afe186a6ba32024-12-06T02:03:20ZengSAGE PublishingCancer Control1526-23592024-11-013110.1177/10732748241305581Decentralized Clinical Trials at Home: Commentary on Caregivers’ BurdenOpeyemi Bolajoko PhDDottington Fullwood EdD, CHESMahin Colissa MPHArnold MerriweatherCallie MerriweatherFolakemi T. Odedina PhD, BPharmDecentralized clinical trials (DCTs) provide the opportunity to bring interventional studies closer to participants in their homes or a suitable location closer to prospective participants, thus increasing participants’ diversity, accrual, retention, health care, and research access. However, little is known about the burden of caring for cancer patients participating in DCTs. This article describes how DCTs might affect the caregivers of cancer patients. The points discussed include how technological challenges for those without adequate digital literacy can overburden participants and their caregivers at home, as well as managing and optimizing research logistics and safe handling of samples. In addition, the shift in labor from the study personnel to the participants and their caregivers in a bid to complete several study procedures on their own can increase the care burden, especially if not well incentivized. Therefore, it is important to accumulate evidence on ways to optimize DCTs, especially in the home environment, without increasing the burden on caregivers, who will be an integral part of the study team and support the research at home.https://doi.org/10.1177/10732748241305581 |
| spellingShingle | Opeyemi Bolajoko PhD Dottington Fullwood EdD, CHES Mahin Colissa MPH Arnold Merriweather Callie Merriweather Folakemi T. Odedina PhD, BPharm Decentralized Clinical Trials at Home: Commentary on Caregivers’ Burden Cancer Control |
| title | Decentralized Clinical Trials at Home: Commentary on Caregivers’ Burden |
| title_full | Decentralized Clinical Trials at Home: Commentary on Caregivers’ Burden |
| title_fullStr | Decentralized Clinical Trials at Home: Commentary on Caregivers’ Burden |
| title_full_unstemmed | Decentralized Clinical Trials at Home: Commentary on Caregivers’ Burden |
| title_short | Decentralized Clinical Trials at Home: Commentary on Caregivers’ Burden |
| title_sort | decentralized clinical trials at home commentary on caregivers burden |
| url | https://doi.org/10.1177/10732748241305581 |
| work_keys_str_mv | AT opeyemibolajokophd decentralizedclinicaltrialsathomecommentaryoncaregiversburden AT dottingtonfullwoodeddches decentralizedclinicaltrialsathomecommentaryoncaregiversburden AT mahincolissamph decentralizedclinicaltrialsathomecommentaryoncaregiversburden AT arnoldmerriweather decentralizedclinicaltrialsathomecommentaryoncaregiversburden AT calliemerriweather decentralizedclinicaltrialsathomecommentaryoncaregiversburden AT folakemitodedinaphdbpharm decentralizedclinicaltrialsathomecommentaryoncaregiversburden |